VIRIDIAN THERAPEUTICS INC (VRDN) Stock Income Statement
NASDAQ:VRDN - Nasdaq - US92790C1045 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 302.00K | 302.00K | 314.00K | 1.77M | 2.96M | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 337.31M | 299.34M | 254.76M | 136.08M | 82.69M | |||
| Research and Development | 274.15M | 237.75M | 159.26M | 100.59M | 56.79M | |||
| Selling, General, and Administrative Expenses | 63.16M | 61.08M | 95.00M | 35.18M | 25.81M | |||
| Operating Income | -337.00M | -299.04M | -254.45M | -134.30M | -79.73M | |||
| Interest Income/Expense | 28.69M | 29.09M | 16.72M | 4.43M | 320.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 0.00 | |||
| Income Before Taxes | -308.32M | -269.95M | -237.73M | -129.87M | -79.41M | |||
| Net Income | -308.32M | -269.95M | -237.73M | -129.87M | -79.41M | |||
| EBITDA | -336.49M | -298.50M | -253.93M | -134.04M | -79.61M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.24 | -3.98 | -5.31 | -4.05 | -6.66 | |||
| Non GAAP EPS | -4.04 | -3.96 | -5.32 | -4.03 | -7.69 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | -102092.38% | -89387.09% | -75711.46% | -7337.29% | -2682.77% | |||
| Operating Profit Margin | -111591.06% | -99018.21% | -81035.03% | -7587.57% | -2693.58% | |||
All data in USD